Sign Up to like & get recommendations! 0
Published in 2025 at "JAMA internal medicine"
DOI: 10.1001/jamainternmed.2025.2058
Abstract: Importance The optimal management strategy for older patients who present with acute coronary syndrome (ACS) remains unclear due to a paucity of randomized evidence. New large and longer-term randomized data are available. Objective To test… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "International journal of cardiology"
DOI: 10.1016/j.ijcard.2017.03.118
Abstract: BACKGROUND An early invasive strategy for patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS) has been recommended. However, patients at greater risk including the elderly are more often managed conservatively. We aimed to elucidate contemporary… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Journal of the American College of Cardiology"
DOI: 10.1016/j.jacc.2017.09.212
Abstract: Current guidelines suggest an early invasive strategy (EIS) over an initial conservative strategy (ICS) in non-ST elevation acute coronary syndrome (NSTE-ACS), particularly for high-risk patients. However, individual randomized controlled trials (RCTs) have shown contrasting results… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Critical Pathways in Cardiology"
DOI: 10.1097/hpc.0000000000000108
Abstract: Background: Predictors of normal or near-normal coronary angiography (NONCAG) in patients with unstable angina/non-ST-elevation myocardial infarction (UA/NSTEMI) and their importance regarding the prognosis are not understood. Accordingly, we determined these predictors as well as mortality… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Circulation: Cardiovascular Interventions"
DOI: 10.1161/circinterventions.121.011506
Abstract: Background: Lifestyle changes and medications are recommended as the first line of treatment for claudication, with revascularization considered for treatment-resistant symptoms, based on patients’ preferences. Real-world evidence comparing health status outcomes of early invasive with… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.989975
Abstract: Background The implementation of sentinel lymph node biopsy (SLNB) and further completion axillary lymph node dissection (cALND) after positive sentinel lymph nodes (SLNs) on early invasive breast cancer patients should be cautiously tailored. Identifying predictors… read more here.